Patent ID: 11964153
Assignee: SAYED EMAL WAHEZI
Field: Medical technology (Instruments)
Classification: CPC A | IPC A

Claim 9:
10. The method of claim 7, wherein the neuromodulation session in the pre-implant trial phase (148) further comprises:
applying each tested waveform protocol (133) for an active application time period and ceasing the application of each tested waveform protocol (133) for an inactive application time period;
storing a time series of samples of the physiological parameters (146), sampled during the active application time period;
storing a time series of samples of the physiological parameters (146), sampled during the inactive application time period; and
establishing the reference pain syndrome tolerance to the tested waveform protocol (133) as a function of a comparison between the active application time series samples and the inactive application time series samples.